Sodium Bicarbonate

  • Description and indication for use

    Alkalinising agent used in the treatment of metabolic acidosis due to bicarbonate loss from kidneys and GI tract or following prolonged resuscitation (may be associated with lactic acidosis).

    Dose

    To correct metabolic acidosis

    Give HALF the mmol deficit, then review.

    mmol deficit = Base excess x Weight (kg).

                                 3

    Reconstitution/Dilution

    Ampoule = sodium bicarbonate 8.4% (1 mmol/mL).

    IV:

    Dilute 1:1 with water for injection (0.5 mmol/mL = 4.2%) ie 1 mL of water for injection for every 1 mL of Sodium Bicarbonate 8.4% solution.

    This is the maximum concentration to be used, 8.4% solution is extremely irritant to vessels and tissues. May be further diluted if necessary.

    Route and method of administration

    Do not administer via arterial (umbilical or peripheral) catheter.

    IV:

    Give slowly over 15 to 30 minutes.

    Rapid IV administration is not recommended

    May cause sudden osmolar shifts and has been associated with IVH.

    Side effects

    May cause hypernatraemia with repeated doses.

    Rapid administration has been associated with IVH.

    Extravasation causes tissue necrosis.

    Contraindications

    Do not administer via arterial (umbilical or peripheral) catheter.

    CAUTION in hypernatraemia (solution contains sodium 1 mmol/mL).

    Nursing responsibilities

    Observe for signs of extravasation.

    Observe routine electrolytes to ensure serum sodium is within normal range.

    Compatibility Information

    IMPORTANT: Contact Pharmacy for drugs not appearing in the table below. Uncommon drugs have simply been omitted and may be incompatible.

    Compatible

    Incompatible

    Fluids

    Glucose 5%, Sodium Chloride 0.9%.

    Intralipid, TPN.

    Drugs

    Amikacin, Aminophylline, Amphotericin B, Atropine Sulphate, Ceftazidime, Cephalothin, Clindamycin, Erythromycin, Flucloxacillin, Frusemide, Heparin Sodium, Hydrocortisone Sodium Succinate, Phenobarbitone, Phenytoin, Verapamil.

    Adrenaline, Amiodarone, Amoxycillin, Benzylpenicillin, Calcium, Cefotaxime, Ciprofloxacin, Dobutamine, Dopamine, Imipenem-Cilastatin, Insulin (Neutral), Isoprenaline, Magnesium, Midazolam, Morphine Sulphate, Noradrenaline, Potassium, Suxamethonium, Thiopentone, Ticarcillin-Clavulanate, Vancomycin.

    Y-Site

    For up to 3 hours: Insulin (Neutral), Morphine Sulphate.

    For up to 4 hours: Aciclovir, Ceftriaxone, Heparin, Piperacillin-Tazobactam, Vancomycin.

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for